AT
JAZZ icon

Arden Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Arden Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-58
Closed -$6K – 549
2020
Q1 		$6K Buy
+58
New +$7.5K ﹤0.01% 628
2018
Q4 		– Sell
-1,892
Closed -$318K – 347
2018
Q3 		$318K Sell
1,892
-26
-1% -$4.47K 0.05% 286
2018
Q2 		$331K Buy
+1,918
New +$314K 0.05% 273

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Arden Trust's JAZZ Position: Q2 2020 in Review

Arden Trust sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 58 shares — an estimated $6K sold.

Arden Trust first reported a position in JAZZ in Q2 2018 and held it in 3 quarters. The position peaked at $331K in Q2 2018. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Arden Trust reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 58 Jazz Pharmaceuticals shares in Q2 2020, an estimated $6K.
  • Arden Trust first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Arden Trust's Jazz Pharmaceuticals position peaked at $331K in Q2 2018.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.